Clinical Trials Browser

Esophageal Squamous Cell Carcinoma × Lapatinib × Gastrointestinal × Clear all

NCT00239200 2008-07-30

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Phase 2 Terminated

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis